"10.1371_journal.pone.0099795","plos one","2014-06-16T00:00:00Z","Stephanie E Brock; Beatriz E Rendon; Dan Xin; Kavitha Yaddanapudi; Robert A Mitchell","Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America","Conceived and designed the experiments: RAM SEB DX. Performed the experiments: RAM SEB BER KY. Analyzed the data: RAM SEB DX BER KY. Contributed reagents/materials/analysis tools: RAM SEB DX KY. Contributed to the writing of the manuscript: RAM SEB.","Robert A. Mitchell is listed on two patents pertaining to the use of the small molecule MIF antagonist, 4-IPP (MIF Antagonists and Methods of Using the Same - USPTO Serial # 12/301,783; Filed – 9/23/10) and novel analogs (Novel Iodo Pyrimidine Derivatives Useful for the Treatment of MIF-implicated Diseases and Conditions - USPTO Serial # 13/498,036; Filed – 12/12/12) for the treatment of human diseases. Neither Mitchell nor any of the other authors have any other relevant declarations relating to employment, consultancy, patents, products in development or modified products and the aforementioned competing interest does not alter the authors' strict adherence to all PLOS ONE policies on sharing data and materials.","2014","06","Stephanie E Brock","SEB",5,TRUE,3,4,5,NA,TRUE,TRUE,FALSE,0,NA,FALSE
